{"company":{"id":9845,"name":"Aspectbiosystems","domain":"aspectbiosystems.com","url":"https://alion.io/company/aspectbiosystems"},"answer":"As of Nov 17, 2026, Alion lists 10 companies most like Aspectbiosystems: BioMimir, Humacyte, NewLimit, Altos Labs, ProKidney, Sffoundation, Secretome Therapeutics, President & CEO AG, CCRM and Mytos.","highlights":["Aspectbiosystems itself has 8 open roles on Alion.","Of them, NewLimit is hiring the most, with 15 open roles.","Altos Labs has raised the most venture funding on record: $3B."],"as_of":"2026-11-17","cite":"Alion, \"Aspectbiosystems competitors and alternatives: 10 similar companies compared on hiring and funding\", as of Nov 17, 2026. https://alion.io/company/aspectbiosystems/competitors","indexable":true,"target":{"name":"Aspectbiosystems","url":"https://alion.io/company/aspectbiosystems","domain":"aspectbiosystems.com","open_roles":8,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Vancouver","country":"CA"},"technologies":["GMP","GCP","Cell Culture"],"hiring_countries":["CA","US"],"similarity":null},"competitors":[{"name":"BioMimir","url":"https://alion.io/company/biomimir","domain":"biomimir.ca","open_roles":0,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"11-50","headquarters":{"city":"Quebec","country":"CA"},"technologies":[],"hiring_countries":[],"similarity":{"score":11.75,"shared_segments":["Regenerative Medicine"],"shared_technologies":[],"same_hq_country":true}},{"name":"Humacyte","url":"https://alion.io/company/humacyte","domain":"humacyte.com","open_roles":12,"open_roles_change":null,"funding":{"total_raised_usd":224999980,"last_round":"venture","last_round_usd":150000000,"last_round_date":"2018-06-25","lead_investors":[]},"size_band":"201-500","headquarters":{"city":"Durham","country":"US"},"technologies":["GMP","CAPA","Veeva"],"hiring_countries":["US"],"similarity":{"score":11.6,"shared_segments":["Regenerative Medicine"],"shared_technologies":["Mandiant capa","GMP","GLP","CAPA"],"same_hq_country":false}},{"name":"NewLimit","url":"https://alion.io/company/newlimit","domain":"newlimit.com","open_roles":15,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"San Francisco","country":"US"},"technologies":["Machine Learning","Python","LLM"],"hiring_countries":["US"],"similarity":{"score":11.55,"shared_segments":["Regenerative Medicine"],"shared_technologies":["qPCR","Flow Cytometry","ELISA","Cell Culture","GMP"],"same_hq_country":false}},{"name":"Altos Labs","url":"https://alion.io/company/altos-labs","domain":"altoslabs.com","open_roles":13,"open_roles_change":null,"funding":{"total_raised_usd":3000000000,"last_round":"venture","last_round_usd":3000000000,"last_round_date":"2022-01-30","lead_investors":[]},"size_band":"1001-5000","headquarters":{"city":"San Francisco","country":"US"},"technologies":["Python","Machine Learning","Diffusion Models"],"hiring_countries":["US","GB"],"similarity":{"score":11.25,"shared_segments":["Regenerative Medicine"],"shared_technologies":["GCP","qPCR","ELISA","Cell Culture","GLP"],"same_hq_country":false}},{"name":"ProKidney","url":"https://alion.io/company/prokidney","domain":"prokidney.com","open_roles":5,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Winston-Salem","country":"US"},"technologies":["GMP","SAS","CAPA"],"hiring_countries":["US"],"similarity":{"score":11.15,"shared_segments":["Regenerative Medicine"],"shared_technologies":["Mandiant capa","Cell Culture","Bioreactors","GMP","GLP"],"same_hq_country":false}},{"name":"Sffoundation","url":"https://alion.io/company/sffoundation","domain":"sffoundation.ca","open_roles":0,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":null,"headquarters":{"city":"Toronto","country":"CA"},"technologies":[],"hiring_countries":[],"similarity":{"score":11,"shared_segments":["Regenerative Medicine"],"shared_technologies":[],"same_hq_country":true}},{"name":"Secretome Therapeutics","url":"https://alion.io/company/secretometherapeutics","domain":"secretometherapeutics.com","open_roles":4,"open_roles_change":null,"funding":{"total_raised_usd":36854247,"last_round":"series_a","last_round_usd":30000000,"last_round_date":"2026-05-27","lead_investors":[]},"size_band":"11-50","headquarters":{"city":"Dallas","country":"US"},"technologies":["ELISA","Flow Cytometry","PCR"],"hiring_countries":["US"],"similarity":{"score":10.7,"shared_segments":["Regenerative Medicine"],"shared_technologies":["GCP","qPCR","Flow Cytometry","ELISA","Cell Culture"],"same_hq_country":false}},{"name":"President & CEO AG","url":"https://alion.io/company/alliancerm","domain":"alliancerm.org","open_roles":0,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Brussels","country":"BE"},"technologies":[],"hiring_countries":[],"similarity":{"score":10.5,"shared_segments":["Regenerative Medicine"],"shared_technologies":[],"same_hq_country":false}},{"name":"CCRM","url":"https://alion.io/company/ccrm","domain":"ccrm.ca","open_roles":8,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":null,"headquarters":{"city":"Toronto","country":"CA"},"technologies":["GMP","CAPA","Copilot"],"hiring_countries":["CA"],"similarity":{"score":10.45,"shared_segments":["Regenerative Medicine"],"shared_technologies":["Mandiant capa","GMP","CAPA"],"same_hq_country":true}},{"name":"Mytos","url":"https://alion.io/company/mytos","domain":"mytos.bio","open_roles":13,"open_roles_change":null,"funding":{"total_raised_usd":19000000,"last_round":"series_a","last_round_usd":19000000,"last_round_date":"2023-11-29","lead_investors":[]},"size_band":"51-200","headquarters":{"city":"London","country":"GB"},"technologies":["GMP","SolidWorks","Heroku"],"hiring_countries":["GB","US"],"similarity":{"score":10.25,"shared_segments":["Regenerative Medicine"],"shared_technologies":["qPCR","Flow Cytometry","Cell Culture","GMP","CAPA"],"same_hq_country":false}}],"method":"Ranked by Alion's similar-companies engine (the MCP tool similar_companies): shared industry segments and the overlap of the two segment sets, technologies named in both companies' job postings, the same headquarters country, a size band near it. Open roles are the visible postings on Alion today; their change is shown only for boards that state posting dates.","html_url":"https://alion.io/company/aspectbiosystems/competitors","json_url":"https://alion.io/company/aspectbiosystems/competitors.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","built_at":"2026-11-17T02:50:30Z","generated_at":"2026-11-18T04:11:22Z"}}